Innovative Pharmaceutical Biotech Limited (0399.HK)

HKD 0.19

(0.53%)

Annual Balance Sheets

(In HKD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 1.38 Billion 1.38 Billion 1.39 Billion 1.4 Billion 1.41 Billion 1.57 Billion
Total Current Assets 9.79 Million 9.88 Million 18.95 Million 28.8 Million 42.18 Million 44.53 Million
Cash And Short Term Investments 3.07 Million 1.33 Million 4.08 Million 8.99 Million 22.93 Million 17.05 Million
Cash and Cash Equivalents 3.07 Million 1.33 Million 4.08 Million 8.99 Million 22.93 Million 17.05 Million
Short Term Investments - - - - - -
Net Receivables 5.11 Million 6.41 Million 9.5 Million 15.32 Million 15.6 Million 21.17 Million
Inventory 1.00 - 1.00 1.00 1.00 -
Other Current Assets 1.6 Million 2.14 Million 14.86 Million 4.48 Million 3.64 Million 6.3 Million
Total Non-Current Assets 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion 1.53 Billion
Net PPE - 941 Thousand 2.82 Million 1.18 Million 3.46 Million 95 Thousand
Good Will And Intangible Assets 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion
Good Will - - - - - -
Intangible Assets 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion 1.37 Billion
Long-Term Investments - - - - - 160.89 Million
Tax Assets - - - - - -160.89 Million
Other Non Current Assets - -1.37 Billion -1.37 Billion -1.37 Billion -1.37 Billion 160.89 Million
Other Assets - - - - - -
Total Liabilities 1.06 Billion 1.24 Billion 999.73 Million 1.04 Billion 851.1 Million 783.94 Million
Total Current Liabilities 391.6 Million 1.14 Billion 99.77 Million 800.67 Million 70.54 Million 32.4 Million
Account Payables 1.85 Million 4.02 Million 8.15 Million 5.47 Million 10.25 Million 21.21 Million
Tax Payables - - - - - -
Short Term Debt 255.8 Million 1.09 Billion 41.88 Million 747.64 Million 9.28 Million 3.91 Million
Deferred Revenue 1.00 - - - - -3.91 Million
Other Current Liabilities 133.94 Million 48.73 Million 49.73 Million 47.54 Million 51 Million 11.18 Million
Total Non Current Liabilities 671.99 Million 96.44 Million 899.95 Million 243.83 Million 780.56 Million 751.54 Million
Long-Term Debt 661.64 Million 96.44 Million 899.95 Million 243.83 Million 780.56 Million 709.58 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 10.34 Million - - - - 41.95 Million
Other Liabilities - - - - - -
Total Equity 319.43 Million 140.56 Million 395.26 Million 358.7 Million 567.77 Million 794.81 Million
Stock Holders Equity -611.51 Million -795.07 Million -549.36 Million -595.35 Million -390.37 Million -74.95 Million
Common Stock 17.23 Million 14.64 Million 14.64 Million 14.64 Million 14.64 Million 14.64 Million
Retained Earnings -2.4 Billion -2.5 Billion -2.26 Billion -2.3 Billion -2.1 Billion -2.35 Billion
Accumulated other comprehensive income 400.32 Million 579.66 Million 579.67 Million 579.49 Million 579.88 Million 1.14 Billion
Common Stock Equity -611.51 Million -795.07 Million -549.36 Million -595.35 Million -390.37 Million -74.95 Million
Capital Lease Obligation - 968 Thousand 2.84 Million 1.11 Million 3.39 Million -
Total Investments - - - - - 160.89 Million
Total Debt 917.44 Million 1.19 Billion 941.83 Million 991.47 Million 789.85 Million 709.58 Million
Net Debt 914.37 Million 1.18 Billion 937.75 Million 982.48 Million 766.91 Million 692.53 Million

Balance Sheet Charts